Ok so GSK paid $ 7 billion for Novartis vaccine unit - What is the sales of Menveo worldwide? I read somewhere the unit lost $ 200 million. Is that accurate?
last time i checked, menveo wasn't the only show in town: http://www.forbes.com/sites/davidkroll/2014/04/07/fda-breakthrough-therapy-designation-for-novartis-bexsero-vaccine-to-prevent-meningitis-b-2/
Novartis Vaccine losses about as much as they sell in Menveo - $250M. Bexsero may be first MenB but it won't be the last or the best.
